Mantle Cell Lymphoma Articles & Analysis
4 news found
Rizo served in a number of oncology drug development functions with increasing responsibilities at Janssen Research and Development, LLC (Janssen), including Senior Director, Compound Development Team Leader for all myeloid assets, Senior Director, Global Clinical Leader for the imetelstat, ibrutinib mantle cell lymphoma (MCL) program, and ...
ByBayer AG
The Test pre-screens a broad panel of cancer drugs on live patient-derived tumor cells with a battery of oncology drugs selected from a menu of targeted and less-toxic medications. ...
Ibrutinib is an FDA approved drug only used to treat mantle cell lymphoma and chronic lymphocytic leukemia. “The PARIS® Test identified a novel therapy, Ibrutinib, that has successfully controlled the patient’s disease with CA 125 levels dropping by over half during the course of treatment and improvement in her symptoms,” ...
Abologix has obtained impressive data with its anti-JAM-C recombinant monoclonal antibody rH225 in an animal Mantle Cell Lymphoma (MCL) NOD/SCID mouse model. In this study the efficacy of rH225 was tested by assessing: the delayed mortality upon Jeko-1 MCL cell injection and the reduction of Jeko-1 cells ...
ByAbologix